Polymorphisms in the KDR and POSTN genes:: Association with breast cancer susceptibility and prognosis

被引:52
作者
Foersti, Asta [1 ]
Jin, Qianren
Altieri, Andrea
Johansson, Robert
Wagner, Kerstin
Enquist, Kerstin
Grzybowska, Ewa
Pamula, Jolanta
Pekala, Wioletta
Hallmans, Goran
Lenner, Per
Hemminki, Kari
机构
[1] DKFZ, German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany
[2] Karolinska Inst, Dept Biosci, Huddinge, Sweden
[3] Norrlands Univ Hosp, Dept Oncol, Umea, Sweden
[4] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden
[5] Maria Sklodowska Curie Inst, Dept Biol Mol, Ctr Oncol, Gliwice, Poland
关键词
breast cancer susceptibility; cancer prognosis; case-control study; KDR; polymorphism; POSTN;
D O I
10.1007/s10549-006-9265-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Angiogenesis is an important step in the development of cancer. Vascular endothelial growth factor is a major regulator of breast cancer angiogenesis, the effects of which are transmitted through the kinase domain receptor (KDR). Up-regulation of KDR by periostin (POSTN) induces angiogenesis. We screened the KDR and the POSTN genes for published single nucleotide polymorphisms (SNPs) and chose two SNPs in each gene for further analyses. We carried out a case-control study consisting of 412 familial and 912 unselected breast cancer cases together with ethnically and geographically selected controls. Genotype, haplotype and genotype combination analyses were carried out to evaluate their effect on susceptibility to and prognosis of breast cancer. A haplotype in the POSTN gene was associated with an increased risk even after correction for multiple comparisons. Nominal associations between the SNPs and prognostic indicators were also observed. Tumors of the KDR 472His allele carriers were less often progesterone receptor negative according to both genotype and haplotype analyses (OR 0.61, 95%CI 0.40-0.92 and OR 0.60, 95%CI 0.40-0.91, respectively). The POSTN -33G allele carriers had more often high grade and estrogen receptor negative tumors (OR 1.75, 95%CI 1.02-3.01 and OR 1.70, 95%CI 1.04-2.78, respectively). The overall and cancer specific survival after 15 years of follow-up was more than 75%, and it did not depend on the genotype. Although a major effect of the SNPs in the KDR and the POSTN genes on breast cancer susceptibility and prognosis was excluded, the effect of the POSTN C-33G SNP on prognosis needs further characterization.
引用
收藏
页码:83 / 93
页数:11
相关论文
共 23 条
[1]   Polygenic inheritance of breast cancer: Implications for design of association studies [J].
Antoniou, AC ;
Easton, DF .
GENETIC EPIDEMIOLOGY, 2003, 25 (03) :190-202
[2]   TGF-β signaling in tumor suppression and cancer progression [J].
Derynck, R ;
Akhurst, RJ ;
Balmain, A .
NATURE GENETICS, 2001, 29 (02) :117-129
[3]   The biology of VEGF and its receptors [J].
Ferrara, N ;
Gerber, HP ;
LeCouter, J .
NATURE MEDICINE, 2003, 9 (06) :669-676
[4]   Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer [J].
Försti, A ;
Jin, QR ;
Grzybowska, E ;
Söderberg, M ;
Zientek, H ;
Sieminska, M ;
Rogozinska-Szczepka, J ;
Chmielik, E ;
Utracka-Hutka, B ;
Hemminki, K .
CARCINOGENESIS, 2002, 23 (08) :1315-1320
[5]   Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor [J].
Fuh, G ;
Li, B ;
Crowley, C ;
Cunningham, B ;
Wells, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (18) :11197-11204
[6]   A high proportion of founder BRCA1 mutations in Polish breast cancer families [J].
Górski, B ;
Jakubowska, A ;
Huzarski, T ;
Byrski, T ;
Gronwald, J ;
Grzybowska, E ;
Mackiewicz, A ;
Stawicka, M ;
Bebenek, M ;
Sorokin, D ;
Fiszer-Maliszewska, L ;
Haus, O ;
Janiszewska, H ;
Niepsuj, S ;
Gózdz, S ;
Zaremba, L ;
Posmyk, M ;
Pluzanska, M ;
Kilar, E ;
Czudowska, D ;
Wasko, B ;
Miturski, R ;
Kowalczyk, JR ;
Urbanski, K ;
Szwiec, M ;
Koc, J ;
Debniak, B ;
Rozmiarek, A ;
Debniak, T ;
Cybulski, C ;
Kowalska, E ;
Toloczko-Grabarek, A ;
Zajaczek, S ;
Menkiszak, J ;
Medrek, K ;
Masojc, B ;
Mierzejewski, M ;
Narod, SA ;
Lubinski, J .
INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (05) :683-686
[7]   The future of association studies of common cancers [J].
Houlston, RS ;
Peto, J .
HUMAN GENETICS, 2003, 112 (04) :434-435
[8]   'Racial' differences in genetic effects for complex diseases [J].
Ioannidis, JPA ;
Ntzani, EE ;
Trikalinos, TA .
NATURE GENETICS, 2004, 36 (12) :1312-1318
[9]   Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis [J].
Jin, QR ;
Hemminki, K ;
Enquist, K ;
Lenner, P ;
Grzybowska, E ;
Klaes, R ;
Henriksson, R ;
Chen, BW ;
Pamula, J ;
Pekala, W ;
Zientek, H ;
Rogozinska-Szczepka, J ;
Utracka-Hutka, B ;
Hallmans, G ;
Försti, A .
CLINICAL CANCER RESEARCH, 2005, 11 (10) :3647-3653
[10]   Polymorphisms and haplotype structures in genes for transforming growth factor β1 and its receptors in familial and unselected breast cancers [J].
Jin, QR ;
Hemminki, K ;
Grzybowska, E ;
Klaes, R ;
Söderberg, M ;
Zientek, H ;
Rogozinska-Szczepka, J ;
Utracka-Hutka, B ;
Pamula, J ;
Pekala, W ;
Försti, A .
INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (01) :94-99